美聯新材(300586.SZ):股東張盛業持股比例累計減少1.07%
格隆匯3月8日丨美聯新材(300586.SZ)公佈,公司於2020年7月發行的“美聯轉債”於2021年1月7日進入轉股期,可轉換公司債券轉股會增加公司總股本。結合“美聯轉債”轉股情況,根據截至2022年3月7日公司股權結構情況,公司總股本為524,481,786股,股東張盛業持有公司股份比例變更為9.40%。
2021年6月30日至2022年3月7日期間,因減持公司股份以及上述可轉換公司債券轉股導致持有公司股份比例被動稀釋,張盛業持有公司股份比例累計減少1.07%,變動比例超過1%。
2021年11月4日至2022年3月7日,張盛業累計減持公司股份559.9910萬股。截至2022年3月7日,張盛業共計持有公司股份4931.0090萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.